Literature DB >> 11341772

ERK mediates effects of glycated albumin in mesangial cells.

M P Cohen1, E Shea, C W Shearman.   

Abstract

The alterations in glomerular cell biology induced by glycated albumin resemble those caused by high ambient glucose, but are operative in physiologic (5.5 mM) glucose concentration. Recently, high glucose has been shown to activate extracellular signal-related kinase (ERK) in mesangial cells, but whether the mitogen-activated protein kinase (MAPK) cascade participates in signal transduction triggered by glycated albumin is unknown. Using a specific inhibitor of MAPK/ERK kinase, we demonstrate for the first time that activation of ERK is required for the inhibition of cell growth and enhanced elaboration of extracellular matrix protein provoked by glycated albumin. These findings indicate that the MAPK/ERK pathway mediates biologic activities of this glycated protein. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341772     DOI: 10.1006/bbrc.2001.4821

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Glycated albumin upregulates upstream stimulatory factor 2 gene transcription in mesangial cells.

Authors:  Yanzhang Li; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

Review 2.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

3.  Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

Authors:  Ahmed S Ibrahim; Azza B El-Remessy; Suraporn Matragoon; Wenbo Zhang; Yogin Patel; Sohail Khan; Mohammed M Al-Gayyar; Mamdouh M El-Shishtawy; Gregory I Liou
Journal:  Diabetes       Date:  2011-02-11       Impact factor: 9.461

4.  Inhibiting Amadori-modified albumin formation improves biomarkers of podocyte damage in diabetic rats.

Authors:  Margo P Cohen; Clyde W Shearman
Journal:  Physiol Rep       Date:  2013-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.